Substance use and work
With the legalization of recreational cannabis in Canada, questions have been raised about patterns of cannabis use at work, the use of cannabis to treat work-related injuries, and the implications of such uses for work productivity, workplace health and safety and work disability management. IWH research examines these questions, as well as questions about the use and effectiveness of narcotics or opioids to treat pain, including pain associated with work injuries, and patterns of opioid-related harms among workers.
Featured
Research Highlights
Rises in opioid harms highest in machining, construction, sales
A new study has found that opioid harm rates have increased among injured workers over the last two decades. The study also breaks the trends down by occupation.
Published: October 14, 2026
Research Highlights
Fatal drug overdoses more common among lower-income and unemployed Canadians
A new IWH study looked at how sociodemographic factors measured by the Canadian census were linked with drug overdose deaths.
Published: March 11, 2026
IWH Speaker Series
IWH Speaker Series
Clearing the haze: Understanding how Canadian workers use and perceive cannabis at work
Recreational cannabis is now legal in Canada and many surveys suggest employers are concerned about the potential implications for workplaces. In this presentation, Dr. Nancy Carnide shares preliminary findings of a survey of workers, conducted in June 2018, aimed at understanding patterns of workplace cannabis use and the social norms and perceptions about such use.
Published: November 2018
At Work article
IWH review outlines promising strategies to prevent prescribed opioid abuse
Since the start of the opioid crisis in the late 1990s, communities across North America have tried many different strategies to curb the misuse and abuse of prescription opioids. A new IWH systematic review identifies the most promising ones.
Published: November 2018
IWH in the media
New systematic review outlines promising strategies to prevent prescribed opioid abuse, overdoses
The opioid epidemic continues to grow unabated across swaths of North America. A new systematic review by the Institute for Work & Health (IWH) now provides a comprehensive assessment of the strategies that have been tried to promote the appropriate use of opioid prescriptions, reduce their misuse and abuse, and prevent overdose deaths.
Published: OOHNA Journal, October 2018
Journal article
Journal article
Prescription dispensing patterns before and after a workers' compensation claim: an historical cohort study of workers with low back pain injuries in British Columbia
Published: Journal of Occupational and Environmental Medicine, July 2018
Journal article
Journal article
A systematic review of strategies to improve appropriate use of opioids and to reduce opioid use disorder and deaths from prescription opioids
Published: Canadian Journal of Pain, June 2018
IWH in the media
Opioids linked to longer disability leaves
A Canadian review of five studies have found a link between opioid prescriptions and longer duration of time on disability, writes Sarah Dobson, who interviews Dr. Nancy Carnide and Dr. Andrea Furlan, among others, about implications of this IWH study.
Published: Canadian HR Reporter, June 2018
IWH in the media
High at the helm: Workplaces preparing for cannabis legalization
Virtually nothing is known about why Canadians use cannabis on the job or how common it is for people to consume it at work, says the Institute for Work & Health's Dr. Nancy Carnide in this article on cannabis in the workplace.
Published: The Globe and Mail, April 2018
At Work article
Studies consistent in finding a link between opioids for MSDs and longer work disability
A systematic review on early opioid prescription for MSDs and work disability finds a consistent link with longer work disability. However, review authors urge caution in drawing a conclusion about cause and effect.
Published: February 2018
IWH in the media
Marijuana in the workplace: What is unsafe?
The federal government’s commitment to legalize recreational marijuana by July 1, 2018 raises occupational health and safety concerns for many employers. At the Institute for Work & Health (IWH), we have been reviewing the effects of various drugs that act on the central nervous system — including marijuana — on workplace injuries, deaths and near-misses, write IWH's Dr. Andrea Furlan and Dr. Nancy Carnide. What is striking is how little high-quality evidence there is on the impacts of marijuana in the workplace and how inconsistent the existing data is.
Published: The Conversation, January 2018
IWH in the media
Companies fret about hazy rules around pot use
Once recreational cannabis use becomes legal, taking a “smoke break” at work could suddenly become much more complicated, writes Cassandra Szklarski of the Canadian Press. The Institute for Work & Health's Dr. Andrea Furlan and Dr. Nancy Carnide are among those interviewed.
Published: National Post, December 2017